We’ve seen patients on transplant lists taken off of them after starting Winrevair, says Merck CEO

Merck Chairman and CEO Robert Davis joins ‘Mad Money’ host Jim Cramer at the JPMorgan Healthcare Conference to talk recent acquisitions, growth in its vaccine segment, opportunities in China and more.